Detection and isolation of circulating tumor cells: Principles and methods

Biotechnology Advances

Volumn 31, Issue 7, 2013, Pages 1063-1084

  Esmaeilsabzali, Hadi ^a   Beischlag, Timothy V ^a   Cox, Michael E ^b,c   Parameswaran, Ash M ^a   Park, Edward J ^a  

^a SIMON FRASER UNIVERSITY   (Canada)

^b JACK BELL RESEARCH CENTRE   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Biomarker; Cancer; Carcinoma; Circulating tumor cell; CTC detection methods; CTC isolation methods; Image cytometry; Immunomagnetic; Metastasis; Microfluidics

Indexed keywords

CANCER; CARCINOMA; CIRCULATING TUMOR CELLS; CTC ISOLATION METHODS; DETECTION METHODS; IMAGE CYTOMETRY; IMMUNOMAGNETIC; METASTASIS;

ANTIBODIES; BIOLOGICAL ORGANS; BIOMARKERS; CARDIOVASCULAR SYSTEM; CELLS; DISEASES; MICROFLUIDICS; NUCLEIC ACIDS;

CHEMICAL DETECTION;

BIOMARKER; BLOOD; CANCER; IMAGE; QUALITATIVE ANALYSIS; RESEARCH; TUMOR;

BIOLOGICAL MARKER; TUMOR MARKER;

BIOTECHNOLOGY; BLOOD; CARCINOMA; CELL SEPARATION; CIRCULATING TUMOR CELL; CTC DETECTION METHODS; CTC ISOLATION METHODS; HUMAN; IMAGE CYTOMETRY; IMMUNOMAGNETIC; METASTASIS; MICROFLUIDIC ANALYSIS; MICROFLUIDICS; NEOPLASM; REVIEW; TUMOR EMBOLISM;

BIOMARKER; CANCER; CARCINOMA; CIRCULATING TUMOR CELL; CTC DETECTION METHODS; CTC ISOLATION METHODS; IMAGE CYTOMETRY; IMMUNOMAGNETIC; METASTASIS; MICROFLUIDICS;

BIOTECHNOLOGY; CELL SEPARATION; HUMANS; MICROFLUIDIC ANALYTICAL TECHNIQUES; NEOPLASTIC CELLS, CIRCULATING; TUMOR MARKERS, BIOLOGICAL;

EID: 84886770488     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2013.08.016     Document Type: Review

References (292)

1. Adams A.A., Okagbare P.I., Feng J., Hupert Matuesz L., Patterson D., Göttert J., et al. Highly efficient circulating tumor cell isolation from whole blood and label-free enumeration using polymer-based microfluidics with an integrated conductivity sensor. J Am Chem Soc 2008, 130:8633-8641.
2. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison Sean J., Clarke Michael F. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003, 100:3983-3988.
3. Alix-Panabières C. EPISPOT assay: detection of viable DTCs/CTCs in solid tumor patients. Recent Results Cancer Res 2012, 195:69-76.
4. Alix-Panabières C., Brouillet J.-P., Fabbro M., Yssel H., Rousset T., Maudelonde T., et al. Characterization and enumeration of cells secreting tumor markers in the peripheral blood of breast cancer patients. J Immunol Methods 2005, 299:177-188.
5. Alix-Panabières C., Vendrell J.-P., Pellé O., Rebillard X., Riethdorf S., Müller V., et al. Detection and characterization of putative metastatic precursor cells in cancer patients. Clin Chem 2007, 53:537-539.
6. Alix-Panabières C., Vendrell J.-P., Slijper M., Pellé O., Barbotte E., Mercier G., et al. Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer. Breast Cancer Res 2009, 11:R39.
7. Allard W.J., Matera J., Miller M.C., Repollet M., Connelly M.C., Rao Chandra, et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 2004, 10:6897-6904.
8. Allen-Mersh T.G., McCullough T.K., Patel H., Wharton R.Q., Glover C., Jonas S.K. Role of circulating tumour cells in predicting recurrence after excision of primary colorectal carcinoma. Br J Surg 2007, 94:96-105.
9. Al-Mehdi A.B., Tozawa K., Fisher A.B., Shientag L., Lee A., Muschel R.J. Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat Med 2000, 6:100-102.
10. Alunni-Fabbroni M., Sandri M.T. Circulating tumour cells in clinical practice: methods of detection and possible characterization. Methods 2010, 50:289-297.
11. American Cancer Society Cancer facts & figures 2013 2013, American Cancer Society, Atlanta.
12. Andreopoulou E., Yang L.-Y., Rangel K.M., Reuben J.M., Hsu L., Krishnamurthy S., et al. Comparison of assay methods for detection of circulating tumor cells in metastatic breast cancer: AdnaGen AdnaTest BreastCancer Select/DetectTM versus Veridex Cell SearchTM system. Int J Cancer 2012, 130:1590-1597.
13. Apel P. Track etching technique in membrane technology. Radiat Meas 2001, 34:559-566.
14. Attard Gerhardt, Swennenhuis J.F., Olmos D., Reid A.H.M., Vickers E., A'Hern R., et al. Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer. Cancer Res 2009, 69:2912-2918.
15. Augustsson P., Magnusson C., Nordin M., Lilja H., Laurell T. Microfluidic, label-free enrichment of prostate cancer cells in blood based on acoustophoresis. Anal Chem 2012, 84:7954-7962.
16. Balasubramanian S., Kagan D., Hu C.-M.J., Campuzano S., Lobo-Castañon M.J., Lim N., et al. Micromachine-enabled capture and isolation of cancer cells in complex media. Angew Chem Int Ed Engl 2011, 50:4161-4164.
17. Barrière G., Riouallon A., Renaudie J., Tartary M., Rigaud M. Mesenchymal and stemness circulating tumor cells in early breast cancer diagnosis. BMC Cancer 2012, 12:114.
18. Bauer K.D., de la Torre-Bueno J., Diel I.J., Hawes D., Decker W.J., Priddy C., et al. Reliable and sensitive analysis of occult bone marrow metastases using automated cellular imaging. Clin Cancer Res 2000, 6:3552-3559.
19. Becker F.F., Wang X.B., Huang Y., Pethig R., Vykoukal J., Gascoyne P.R. Separation of human breast cancer cells from blood by differential dielectric affinity. Proc Natl Acad Sci U S A 1995, 92:860-864.
20. Bednarz-Knoll N., Alix-Panabières C., Pantel Klaus Plasticity of disseminating cancer cells in patients with epithelial malignancies. Cancer Metastasis Rev 2012, 31:673-687.
21. Berezovskaya O., Schimmer A.D., Glinskii A.B., Pinilla C., Hoffman R.M., Reed J.C., et al. Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells. Cancer Res 2005, 65:2378-2386.
22. Bernards R., Weinberg Robert A. A progression puzzle. Nature 2002, 418:823.
23. Berois N., Varangot M., Aizen B., Estrugo R., Zarantonelli L., Fernández P., et al. Molecular detection of cancer cells in bone marrow and peripheral blood of patients with operable breast cancer. Comparison of CK19, MUC1 and CEA using RT-PCR. Eur J Cancer 2000, 36:717-723.
24. Bertazza L., Mocellin S., Nitti D. Circulating tumor cells in solid cancer: tumor marker of clinical relevance?. Curr Oncol Rep 2008, 10:137-146.
25. Bhagat A.A.S., Bow H., Hou H.W., Tan S.J., Han J., Lim C.T. Microfluidics for cell separation. Med Biol Eng Comput 2010, 48:999-1014.
26. Bhagat A.A.S., Hou H.W., Li L.D., Lim C.T., Han J. Pinched flow coupled shear-modulated inertial microfluidics for high-throughput rare blood cell separation. Lab Chip 2011, 11:1870-1878.
27. Bidard F.-C., Mathiot C., Delaloge S., Brain E., Giachetti S., de Cremoux P., et al. Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer. Ann Oncol 2010, 21:729-733.
28. Bossolasco P., Ricci C., Farina G., Soligo D., Pedretti D., Scanni A., et al. Detection of micrometastatic cells in breast cancer by RT-pCR for the mammaglobin gene. Cancer Detect Prev 2002, 26:60-63.
29. Broche L.M., Bhadal N., Lewis M.P., Porter S., Hughes M.P., Labeed F.H. Early detection of oral cancer - is dielectrophoresis the answer?. Oral Oncol 2007, 43:199-203.
30. Budd G.T., Cristofanilli M., Ellis Mathew J., Stopeck Allison, Borden E., Miller M.C., et al. Circulating tumor cells versus imaging-predicting overall survival in metastatic breast cancer. Clin Cancer Res 2006, 12:6403-6409.
31. Cann G.M., Gulzar Z.G., Cooper S., Li R., Luo S., Tat M., et al. mRNA-Seq of single prostate cancer circulating tumor cells reveals recapitulation of gene expression and pathways found in prostate cancer. PLoS One 2012, 7:e49144.
32. Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases. Nature 2000, 407:249-257.
33. Cen E.G., Dalton C., Li Youlan, Adamia S., Pilarski L.M., Kaler K.V.I.S. A combined dielectrophoresis, traveling wave dielectrophoresis and electrorotation microchip for the manipulation and characterization of human malignant cells. J Microbiol Methods 2004, 58:387-401.
34. Cerchia L., de Franciscis V. Targeting cancer cells with nucleic acid aptamers. Trends Biotechnol 2010, 28:517-525.
35. Chaffer C.L., Weinberg Robert A. A perspective on cancer cell metastasis. Science 2011, 331:1559-1564.
36. Chambers Ann F., Groom Alan C., MacDonald Ian C. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002, 2:563-572.
37. Chang K.C., Hammer D.A. The forward rate of binding of surface-tethered reactants: effect of relative motion between two surfaces. Biophys J 1999, 76:1280-1292.
38. Chang Y.S., di Tomaso E., McDonald D.M., Jones R., Jain R.K., Munn L.L. Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. Proc Natl Acad Sci U S A 2000, 97:14608-14613.
39. Chelly J., Concordet J.P., Kaplan J.C., Kahn A. Illegitimate transcription: transcription of any gene in any cell type. Proc Natl Acad Sci U S A 1989, 86:2617-2621.
40. Chen Z., Zhang S., Tang Zuming, Xiao P., Guo X., Lu Z. Pool-dam structure based microfluidic devices for filtering tumor cells from blood mixtures. Surf Interface Anal 2006, 38:996-1003.
41. Cheng J., Sheldon E.L., Wu L., Heller M.J., O'Connell J.P. Isolation of cultured cervical carcinoma cells mixed with peripheral blood cells on a bioelectronic chip. Anal Chem 1998, 70:2321-2326.
42. Cheung L.S., Zheng X., Wang Lian, Guzman R., Schroeder J.A., Heimark R.L., et al. Kinematics of specifically captured circulating tumor cells in Bio-functionalized microchannels. J Microelectromech Syst 2010, 19:752-763.
43. Cheung L.S.-L., Zheng X., Wang Lian, Baygents James C., Guzman Roberto, Schroeder Joyce A., et al. Adhesion dynamics of circulating tumor cells under shear flow in a bio-functionalized microchannel. J Micromech Microeng 2011, 21:054033.
44. Chiang A.C., Massagué J. Molecular basis of metastasis. N Engl J Med 2008, 359:2814-2823.
45. Cho E.H., Wendel M., Luttgen M., Yoshioka C., Marrinucci D., Lazar D., et al. Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors. Phys Biol 2012, 9:016001.
46. Christiansen J.J., Rajasekaran A.K. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res 2006, 66:8319-8326.
47. Clarke Michael F., Dick J.E., Dirks P.B., Eaves C.J., Jamieson C.H.M., Jones D.L., et al. Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 2006, 66:9339-9344.
48. Cohen S.J., Punt C.J.A., Iannotti N., Saidman B.H., Sabbath K.D., Gabrail N.Y., et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 2008, 26:3213-3221.
49. Collins A.T., Berry P.A., Hyde C., Stower M.J., Maitland N.J. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005, 65:10946-10951.
50. Coumans F.A.W., Doggen C.J.M., Attard G., de Bono J.S., Terstappen L.W.M.M. All circulating EpCAM+CK+CD45- objects predict overall survival in castration-resistant prostate cancer. Ann Oncol 2010, 21:1851-1857.
51. Crisan D., Ruark D.S., Decker D.A., Drevon A.M., Dicarlo R.G. Detection of circulating epithelial cells after surgery for benign breast disease. Mol Diagn 2000, 5:33-38.
52. Cristofanilli M. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. Semin Oncol 2006, 33:S9-S14.
53. Cristofanilli M., Budd G.T., Ellis Matthew J., Stopeck Alison, Matera J., Miller M.C., et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004, 351:781-791.
54. Cristofanilli M., Hayes D.F., Budd G.T., Ellis Mathew J., Stopeck Alison, Reuben J.M., et al. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol 2005, 23:1420-1430.
55. Cross S.E., Jin Y.-S., Rao J., Gimzewski J.K. Nanomechanical analysis of cells from cancer patients. Nat Nanotechnol 2007, 2:780-783.
56. Cruz I., Ciudad J., Cruz J.J., Ramos M., Gómez-Alonso A., Adansa J.C., et al. Evaluation of multiparameter flow cytometry for the detection of breast cancer tumor cells in blood samples. Am J Clin Pathol 2005, 123:66-74.
57. Darzynkiewicz Z., Bedner E., Li X., Gorczyca W., Melamed M.R. Laser-scanning cytometry: a new instrumentation with many applications. Exp Cell Res 1999, 249:1-12.
58. Davis J.A., Inglis D.W., Morton K.J., Lawrence D.A., Huang Lotien R., Chou S.Y., et al. Deterministic hydrodynamics: taking blood apart. Proc Natl Acad Sci U S A 2006, 103:14779-14784.
59. De Giorgi U., Mego M., Scarpi E., Giuliano M., Giordano A., Reuben J.M., et al. Relationship between lymphocytopenia and circulating tumor cells as prognostic factors for overall survival in metastatic breast cancer. Clin Breast Cancer 2012, 12:264-269.
60. Deng G., Herrler M., Burgess D., Manna E., Krag D., Burke J.F. Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients. Breast Cancer Res 2008, 10:R69.
61. Desitter I., Guerrouahen B.S., Benali-Furet N., Wechsler J., Jänne Pasi A., Kuang Y., et al. A new device for rapid isolation by size and characterization of rare circulating tumor cells. Anticancer Res 2011, 31:427-441.
62. Devriese L.A., Voest E.E., Beijnen J.H., Schellens J.H.M. Circulating tumor cells as pharmacodynamic biomarker in early clinical oncological trials. Cancer Treat Rev 2011, 37:579-589.
63. Dharmasiri U., Balamurugan S., Adams A.A., Okagbare P.I., Obubuafo A., Soper S.A. Highly efficient capture and enumeration of low abundance prostate cancer cells using prostate-specific membrane antigen aptamers immobilized to a polymeric microfluidic device. Electrophoresis 2009, 30:3289-3300.
64. Dharmasiri U., Njoroge S.K., Witek M.A., Adebiyi M.G., Kamande J.W., Hupert Mateusz L., et al. High-throughput selection, enumeration, electrokinetic manipulation, and molecular profiling of low-abundance circulating tumor cells using a microfluidic system. Anal Chem 2011, 83:2301-2309.
65. Diamandis E.P., Pantel Klaus, Scher H.I., Terstappen L., Lianidou E. Circulating cancer cells and their clinical applications. Clin Chem 2011, 57:1478-1484.
66. Didar T.F., Tabrizian M. Adhesion based detection, sorting and enrichment of cells in microfluidic Lab-on-Chip devices. Lab Chip 2010, 10:3043-3053.
67. Doyen J., Alix-Panabières C., Hofman P., Parks S.K., Chamorey E., Naman H., et al. Circulating tumor cells in prostate cancer: a potential surrogate marker of survival. Crit Rev Oncol Hematol 2012, 81:241-256.
68. Dunn G.P., Bruce A.T., Ikeda H., Old L.J., Schreiber R.D. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 2002, 3:991-998.
69. Eaves C.J. Cancer stem cells: here, there, everywhere?. Nature 2008, 456:581-582.
70. Engel J., Eckel R., Kerr J., Schmidt M., Fürstenberger G., Richter R., et al. The process of metastasisation for breast cancer. Eur J Cancer 2003, 39:1794-1806.
71. Fan T., Zhao Q., Chen J.J., Chen W.-T., Pearl M.L. Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer. Gynecol Oncol 2009, 112:185-191.
72. Fehm Tanja, Sagalowsky A., Clifford E., Beitsch P., Saboorian H., Euhus David, et al. Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clin Cancer Res 2002, 8:2073-2084.
73. Fehm T., Solomayer E.F., Meng S., Tucker T., Lane N., Wang J., et al. Methods for isolating circulating epithelial cells and criteria for their classification as carcinoma cells. Cytotherapy 2005, 7:171-185.
74. Fehm Tanja, Hoffmann O., Aktas B., Becker S., Solomayer Erich F., Wallwiener D., et al. Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells. Breast Cancer Res 2009, 11:R59.
75. Fehm T., Müller V., Aktas B., Janni W., Schneeweiss A., Stickeler E., et al. HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial. Breast Cancer Res Treat 2010, 124:403-412.
76. Ferlay J., Shin H., Bray F., Forman D., Mathers C., Parkin D. GLOBOCAN 2008 [WWW Document] [accessed 3.26.13]. http://globocan.iarc.fr/.
77. Fidler Isaiah J. The pathogenesis of cancer metastasis: the "seed and soil" hypothesis revisited. Nat Rev Cancer 2003, 3:453-458.
78. Fiedler S., Shirley S.G., Schnelle T., Fuhr G. Dielectrophoretic sorting of particles and cells in a microsystem. Anal Chem 1998, 70:1909-1915.
79. Flores L.M., Kindelberger D.W., Ligon A.H., Capelletti M., Fiorentino M., Loda M., et al. Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancer. Br J Cancer 2010, 102:1495-1502.
80. Forbes T.P., Forry S.P. Microfluidic magnetophoretic separations of immunomagnetically labeled rare mammalian cells. Lab Chip 2012, 12:1471-1479.
81. Franken B., de Groot M.R., Mastboom W.J., Vermes I., van der Palen J., Tibbe A.G., et al. Circulating tumor cells, disease recurrence and survival in newly diagnosed breast cancer. Breast Cancer Res 2012, 14:R133.
82. Friedl P., Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 2003, 3:362-374.
83. Frisch S.M., Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994, 124:619-626.
84. Frisch S.M., Screaton R.A. Anoikis mechanisms. Curr Opin Cell Biol 2001, 13:555-562.
85. Gascoyne P.R.C., Vykoukal Jody Particle separation by dielectrophoresis. Electrophoresis 2002, 23:1973-1983.
86. Gascoyne P.R.C., Wang X.-B., Huang Ying, Becker Frederick F. Dielectrophoretic separation of cancer cells from blood. IEEE Trans Ind Appl 1997, 33:670-678.
87. Gascoyne P.R.C., Noshari J., Anderson T.J., Becker Frederick F. Isolation of rare cells from cell mixtures by dielectrophoresis. Electrophoresis 2009, 30:1388-1398.
88. Gassmann P., Haier J. The tumor cell-host organ interface in the early onset of metastatic organ colonisation. Clin Exp Metastasis 2008, 25:171-181.
89. Gerges N., Rak J., Jabado N. New technologies for the detection of circulating tumour cells. Br Med Bull 2010, 94:49-64.
90. Gervasoni A., Sandri M.T., Nascimbeni R., Zorzino L., Cassatella M.C., Baglioni L., et al. Comparison of three distinct methods for the detection of circulating tumor cells in colorectal cancer patients. Oncol Rep 2011, 25:1669-1703.
91. Ghazani A.A., Castro C.M., Gorbatov R., Lee H., Weissleder R. Sensitive and direct detection of circulating tumor cells by multimarker μ-nuclear magnetic resonance. Neoplasia 2012, 14:388-395.
92. Gleghorn J.P., Pratt E.D., Denning D., Liu H., Bander N.H., Tagawa S.T., et al. Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody. Lab Chip 2010, 10:27-29.
93. Gonzalez C.F., Remcho V.T. Harnessing dielectric forces for separations of cells, fine particles and macromolecules. J Chromatogr A 2005, 1079:59-68.
94. Gozuacik D., Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene 2004, 23:2891-2906.
95. Gradilone A., Raimondi C., Nicolazzo C., Petracca A., Gandini O., Vincenzi B., et al. Circulating tumour cells lacking cytokeratin in breast cancer: the importance of being mesenchymal. J Cell Mol Med 2011, 15:1066-1070.
96. Grützkau A., Radbruch Andreas Small but mighty: how the MACS-technology based on nanosized superparamagnetic particles has helped to analyze the immune system within the last 20years. Cytometry A 2010, 77:643-647.
97. Guck J., Schinkinger S., Lincoln B., Wottawah F., Ebert S., Romeyke M., et al. Optical deformability as an inherent cell marker for testing malignant transformation and metastatic competence. Biophys J 2005, 88:3689-3698.
98. Gupta G.P., Massagué J. Cancer metastasis: building a framework. Cell 2006, 127:679-695.
99. Gupta P.B., Chaffer C.L., Weinberg Robert A. Cancer stem cells: mirage or reality?. Nat Med 2009, 15:1010-1012.
100. Gupta V., Jafferji I., Garza M., Melnikova V.O., Hasegawa D.K., Pethig Ronald, et al. ApoStream™, a new dielectrophoretic device for antibody independent isolation and recovery of viable cancer cells from blood. Biomicrofluidics 2012, 6. [024133-024133-14].
101. Hager G., Cacsire-Castillo Tong D., Schiebel I., Rezniczek G.A., Watrowski R., Speiser P., et al. The use of a panel of monoclonal antibodies to enrich circulating breast cancer cells facilitates their detection. Gynecol Oncol 2005, 98:211-216.
102. Han K.-H., Bruno Frazier A. Continuous magnetophoretic separation of blood cells in microdevice format. J Appl Phys 2004, 96:5797-5802.
103. Han K.-H., Han A., Frazier A.B. Microsystems for isolation and electrophysiological analysis of breast cancer cells from blood. Biosens Bioelectron 2006, 21:1907-1914.
104. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
105. Hanahan Douglas, Weinberg Robert A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
106. Hanna N., Fidler I.J. Role of natural killer cells in the destruction of circulating tumor emboli. J Natl Cancer Inst 1980, 65:801-809.
107. Haun J.B., Devaraj N.K., Hilderbrand S.A., Lee H., Weissleder R. Bioorthogonal chemistry amplifies nanoparticle binding and enhances the sensitivity of cell detection. Nat Nanotechnol 2010, 5:660-665.
108. Hayes D.F., Smerage J. Is there a role for circulating tumor cells in the management of breast cancer?. Clin Cancer Res 2008, 14:3646-3650.
109. He W., Wang Haifeng, Hartmann L.C., Cheng J.-X., Low P.S. In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry. Proc Natl Acad Sci U S A 2007, 104:11760-11765.
110. Hiltermann T.J.N., Pore M.M., van den Berg A., Timens W., Boezen H.M., Liesker J.J.W., et al. Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor. Ann Oncol 2012, 23:2937-2942.
111. Hofman V.J., Ilie M.I., Bonnetaud C., Selva E., Long E., Molina T., et al. Cytopathologic detection of circulating tumor cells using the isolation by size of epithelial tumor cell method: promises and pitfalls. Am J Clin Pathol 2011, 135:146-156.
112. Holmgren L., O'Reilly M.S., Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1995, 1:149-153.
113. Hoshino K., Huang Y.-Y., Lane Nancy, Huebschman M., Uhr Jonathan W., Frenkel E.P., et al. Microchip-based immunomagnetic detection of circulating tumor cells. Lab Chip 2011, 11:3449-3457.
114. Hosokawa M., Hayata T., Fukuda Y., Arakaki A., Yoshino T., Tanaka T., et al. Size-selective microcavity array for rapid and efficient detection of circulating tumor cells. Anal Chem 2010, 82:6629-6635.
115. Hou J.-M., Krebs M.G., Lancashire L., Sloane R., Backen A., Swain R.K., et al. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer. J Clin Oncol 2012, 30:525-532.
116. Hou H.W., Warkiani M.E., Khoo B.L., Li Z.R., Soo R.A., Tan D.S.-W., et al. Isolation and retrieval of circulating tumor cells using centrifugal forces. Sci Rep 2013, 3:1259.
117. Hsieh H.Ben, Marrinucci D., Bethel K., Curry D.N., Humphrey M., Krivacic R.T., et al. High speed detection of circulating tumor cells. Biosens Bioelectron 2006, 21:1893-1899.
118. Huang Ying, Joo S., Duhon M., Heller M., Wallace B., Xu Xiao Dielectrophoretic cell separation and gene expression profiling on microelectronic chip arrays. Anal Chem 2002, 74:3362-3371.
119. Huang Lotien Richard, Cox E.C., Austin R.H., Sturm J.C. Continuous particle separation through deterministic lateral displacement. Science 2004, 304:987-990.
120. Huang R., Barber T.A., Schmidt M.A., Tompkins R.G., Toner M., Bianchi D.W., et al. A microfluidics approach for the isolation of nucleated red blood cells (NRBCs) from the peripheral blood of pregnant women. Prenat Diagn 2008, 28:892-899.
121. Hughes A.D., Mattison J., Western L.T., Powderly J.D., Greene B.T., King M.R. Microtube device for selectin-mediated capture of viable circulating tumor cells from blood. Clin Chem 2012, 58:846-853.
122. Hugo H., Ackland M.L., Blick T., Lawrence M.G., Clements J.A., Williams E.D., et al. Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol 2007, 213:374-383.
123. Hur S.C., Mach A.J., Di Carlo D. High-throughput size-based rare cell enrichment using microscale vortices. Biomicrofluidics 2011, 5:22206.
124. Hüsemann Y., Geigl J.B., Schubert F., Musiani P., Meyer M., Burghart E., et al. Systemic spread is an early step in breast cancer. Cancer Cell 2008, 13:58-68.
125. Hyun K.-A., Kwon K., Han H., Kim S.-I., Jung H.-I. Microfluidic flow fractionation device for label-free isolation of circulating tumor cells (CTCs) from breast cancer patients. Biosens Bioelectron 2013, 40:206-212.
126. Iinuma H., Watanabe T., Mimori K., Adachi M., Hayashi N., Tamura J., et al. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer. J Clin Oncol 2011, 29:1547-1555.
127. Issadore D., Chung J., Shao H., Liong M., Ghazani A.A., Castro C.M., et al. Ultrasensitive clinical enumeration of rare cells ex vivo using a micro-hall detector. Sci Transl Med 2012, 4:141ra92.
128. Jemal A., Bray Freddie, Center M.M., Ferlay Jacques, Ward E., Forman David Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
129. Joosse S.A., Pantel Klaus Biologic challenges in the detection of circulating tumor cells. Cancer Res 2013, 73:8-11.
130. Joyce J.A., Pollard J.W. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009, 9:239-252.
131. Kaiser J. Cancer's circulation problem. Science 2010, 327:1072-1074.
132. Kalluri R., Weinberg Robert A. The basics of epithelial-mesenchymal transition. J Clin Invest 2009, 119:1420-1428.
133. Kamentsky L.A., Burger D.E., Gershman R.J., Kamentsky L.D., Luther E. Slide-based laser scanning cytometry. Acta Cytol 1997, 41:123-143.
134. Kang Y., Massagué J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 2004, 118:277-279.
135. Kang J.H., Krause S., Tobin H., Mammoto A., Kanapathipillai M., Ingber D.E. A combined micromagnetic-microfluidic device for rapid capture and culture of rare circulating tumor cells. Lab Chip 2012, 12:2175-2181.
136. Kim S., Han S.-I., Park M.-J., Jeon C.-W., Joo Y.-D., Choi I.-H., et al. Circulating tumor cell microseparator based on lateral magnetophoresis and immunomagnetic nanobeads. Anal Chem 2013, 85:2779-2786.
137. Kirby B.J., Jodari M., Loftus M.S., Gakhar G., Pratt E.D., Chanel-Vos C., et al. Functional characterization of circulating tumor cells with a prostate-cancer-specific microfluidic device. PLoS One 2012, 7:e35976.
138. Kohn E.C., Liotta L.A. Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res 1995, 55:1856-1862.
139. Kong D., Li Yiwei, Wang Z., Sarkar F.H. Cancer stem cells and epithelial-to-mesenchymal transition (EMT)-phenotypic cells: are they cousins or twins?. Cancers (Basel) 2011, 3:716-729.
140. ® system: a feasibility study. Cytometry B Clin Cytom 2011, 80:112-118.
141. Kraeft S.K., Sutherland R., Gravelin L., Hu G.H., Ferland L.H., Richardson P., et al. Detection and analysis of cancer cells in blood and bone marrow using a rare event imaging system. Clin Cancer Res 2000, 6:434-442.
142. Kralj J.G., Arya C., Tona A., Forbes T.P., Munson M.S., Sorbara L., et al. A simple packed bed device for antibody labelled rare cell capture from whole blood. Lab Chip 2012, 12:4972-4975.
143. Krebs M.G., Hou J.-M., Ward T.H., Blackhall F.H., Dive C. Circulating tumour cells: their utility in cancer management and predicting outcomes. Ther Adv Med Oncol 2010, 2:351-365.
144. Krebs M.G., Sloane R., Priest L., Lancashire L., Hou J.-M., Greystoke A., et al. Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. J Clin Oncol 2011, 29:1556-1563.
145. Krebs M.G., Hou J.-M., Sloane R., Lancashire L., Priest L., Nonaka D., et al. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches. J Thorac Oncol 2012, 7:306-315.
146. Krell J., Stebbing J. Circulating tumour cells as biomarkers in early breast cancer. Lancet Oncol 2012, 13:653-654.
147. Krivacic R.T., Ladanyi A., Curry D.N., Hsieh H.B., Kuhn P., Bergsrud D.E., et al. A rare-cell detector for cancer. Proc Natl Acad Sci U S A 2004, 101:10501-10504.
148. Krüger W., Datta C., Badbaran A., Tögel F., Gutensohn K., Carrero I., et al. Immunomagnetic tumor cell selection-implications for the detection of disseminated cancer cells. Transfusion 2000, 40:1489-1493.
149. Kuntaegowdanahalli S.S., Bhagat A.A.S., Kumar G., Papautsky I. Inertial microfluidics for continuous particle separation in spiral microchannels. Lab Chip 2009, 9:2973-2980.
150. Kuo J.S., Zhao Y., Schiro P.G., Ng Laiying, Lim D.S.W., Shelby J.P., et al. Deformability considerations in filtration of biological cells. Lab Chip 2010, 10:837-842.
151. Kurkuri M.D., Al-Ejeh F., Shi J.Y., Palms D., Prestidge C., Griesser H.J., et al. Plasma functionalized PDMS microfluidic chips: towards point-of-care capture of circulating tumor cells. J Mater Chem 2011, 21:8841-8848.
152. Lacroix M. Significance, detection and markers of disseminated breast cancer cells. Endocr Relat Cancer 2006, 13:1033-1067.
153. Lara O., Tong X., Zborowski Maciej, Chalmers J.J. Enrichment of rare cancer cells through depletion of normal cells using density and flow-through, immunomagnetic cell separation. Exp Hematol 2004, 32:891-904.
154. Leber M.F., Efferth T. Molecular principles of cancer invasion and metastasis (review). Int J Oncol 2009, 34:881-895.
155. Ledford H. Cancer theory faces doubts. Nature 2011, 472:273.
156. Li C., Heidt D.G., Dalerba Piero, Burant C.F., Zhang Lanjing, Adsay V., et al. Identification of pancreatic cancer stem cells. Cancer Res 2007, 67:1030-1037.
157. Li C., Lee C.J., Simeone D.M. Identification of human pancreatic cancer stem cells. Methods Mol Biol 2009, 568:161-173.
158. Liberti P.A., Rao C.G., Terstappen Leon W.M.M. Optimization of ferrofluids and protocols for the enrichment of breast tumor cells in blood. J Magn Magn Mater 2001, 225:301-307.
159. Lien K.-Y., Chuang Y.-H., Hung L.-Y., Hsu K.-F., Lai W.-W., Ho C.-L., et al. Rapid isolation and detection of cancer cells by utilizing integrated microfluidic systems. Lab Chip 2010, 10:2875-2886.
160. Lin M.X., Hyun K.-A., Moon H.-S., Sim T.S., Lee J.-G., Park J.C., et al. Continuous labeling of circulating tumor cells with microbeads using a vortex micromixer for highly selective isolation. Biosens Bioelectron 2013, 40:63-67.
161. Liotta L.A., Stetler-Stevenson W.G. Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 1991, 51:5054s-5059s.
162. Liu Z., Fusi A., Klopocki E., Schmittel A., Tinhofer I., Nonnenmacher A., et al. Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients. J Transl Med 2011, 9:70.
163. Lowes L.E., Goodale D., Keeney M., Allan A.L. Image cytometry analysis of circulating tumor cells. Methods Cell Biol 2011, 102:261-290.
164. Lu J., Fan T., Zhao Q., Zeng W., Zaslavsky E., Chen J.J., et al. Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients. Int J Cancer 2010, 126:669-683.
165. Lucci A., Hall C.S., Lodhi A.K., Bhattacharyya A., Anderson A.E., Xiao L., et al. Circulating tumour cells in non-metastatic breast cancer: a prospective study. Lancet Oncol 2012, 13:688-695.
166. Luzzi K.J., MacDonald I.C., Schmidt E.E., Kerkvliet N., Morris V.L., Chambers A.F., et al. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 1998, 153:865-873.
167. Magbanua M.J.M., Sosa E.V., Scott J.H., Simko Jeff, Collins C., Pinkel D., et al. Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer. BMC Cancer 2012, 12:78.
168. Man Y., Wang Q., Kemmner W. Currently used markers for CTC isolation - advantages, limitations and impact on cancer prognosis. J Clin Exp Pathol 2011, 01.
169. Markou A., Strati A., Malamos N., Georgoulias V., Lianidou E.S. Molecular characterization of circulating tumor cells in breast cancer by a liquid bead array hybridization assay. Clin Chem 2011, 57:421-430.
170. Marrinucci D., Bethel K., Kolatkar A., Luttgen M.S., Malchiodi M., Baehring F., et al. Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers. Phys Biol 2012, 9:016003.
171. Mathew R., Karantza-Wadsworth V., White E. Role of autophagy in cancer. Nat Rev Cancer 2007, 7:961-967.
172. Mavroudis D. Circulating cancer cells. Ann Oncol 2010, 21(Suppl. 7):vii95-vii100.
173. McCloskey K.E., Chalmers J.J., Zborowski Maciej Magnetic cell separation: characterization of magnetophoretic mobility. Anal Chem 2003, 75:6868-6874.
174. Mikolajczyk S.D., Millar L.S., Tsinberg P., Coutts S.M., Zomorrodi M., Pham T., et al. Detection of EpCAM-negative and cytokeratin-negative circulating tumor cells in peripheral blood. J Oncol 2011, 252361.
175. Miller M.C., Doyle G.V., Terstappen Leon WMM Significance of circulating tumor cells detected by the cell search system in patients with metastatic breast colorectal and prostate cancer. J Oncol 2010, 617421.
176. Miltenyi S., Müller W., Weichel W., Radbruch A. High gradient magnetic cell separation with MACS. Cytometry 1990, 11:231-238.
177. Mittal S., Wong I.Y., Deen W.M., Toner Mehmet Antibody-functionalized fluid-permeable surfaces for rolling cell capture at high flow rates. Biophys J 2012, 102:721-730.
178. Mocellin S., Keilholz U., Rossi C.R., Nitti D. Circulating tumor cells: the "leukemic phase" of solid cancers. Trends Mol Med 2006, 12:130-139.
179. Mohamed H., Murray M., Turner J.N., Caggana M. Isolation of tumor cells using size and deformation. J Chromatogr A 2009, 1216:8289-8295.
180. Moon H.-S., Kwon K., Kim S.-I., Han H., Sohn J., Lee S., et al. Continuous separation of breast cancer cells from blood samples using multi-orifice flow fractionation (MOFF) and dielectrophoresis (DEP). Lab Chip 2011, 11:1118-1125.
181. Mostert B., Kraan J., Bolt-de Vries J., van der Spoel P., Sieuwerts A.M., Schutte M., et al. Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146. Breast Cancer Res Treat 2011, 127:33-41.
182. Müller V., Stahmann N., Riethdorf S., Rau T., Zabel T., Goetz A., et al. Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity. Clin Cancer Res 2005, 11:3678-3685.
183. Nagrath S., Sequist L.V., Maheswaran S., Bell D.W., Irimia D., Ulkus L., et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 2007, 450:1235-1239.
184. Naume B., Borgen E., Tøssvik S., Pavlak N., Oates D., Nesland J.M. Detection of isolated tumor cells in peripheral blood and in BM: evaluation of a new enrichment method. Cytotherapy 2004, 6:244-252.
185. Nieva J., Wendel M., Luttgen M.S., Marrinucci D., Bazhenova L., Kolatkar A., et al. High-definition imaging of circulating tumor cells and associated cellular events in non-small cell lung cancer patients: a longitudinal analysis. Phys Biol 2012, 9:016004.
186. Nora Dickson M., Tsinberg P., Tang Zhongliang, Bischoff F.Z., Wilson T., Leonard E.F. Efficient capture of circulating tumor cells with a novel immunocytochemical microfluidic device. Biomicrofluidics 2011, 5:34119-3411915.
187. Ntouroupi T.G., Ashraf S.Q., McGregor S.B., Turney B.W., Seppo A., Kim Y., et al. Detection of circulating tumour cells in peripheral blood with an automated scanning fluorescence microscope. Br J Cancer 2008, 99:789-795.
188. O'Brien C.A., Pollett A., Gallinger S., Dick J.E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007, 445:106-110.
189. O'Brien C.M., Rood K.D., Bhattacharyya K., DeSouza T., Sengupta S., Gupta S.K., et al. Capture of circulating tumor cells using photoacoustic flowmetry and two phase flow. J Biomed Opt 2012, 17:061221.
190. O'Hara S.M., Moreno J.G., Zweitzig D.R., Gross S., Gomella L.G., Terstappen Leon W.M.M. Multigene reverse transcription-PCR profiling of circulating tumor cells in hormone-refractory prostate cancer. Clin Chem 2004, 50:826-835.
191. Pachmann K., Clement J.H., Schneider C.-P., Willen B., Camara O., Pachmann U., et al. Standardized quantification of circulating peripheral tumor cells from lung and breast cancer. Clin Chem Lab Med 2005, 43:617-627.
192. Pachmann K., Camara O., Kavallaris A., Krauspe S., Malarski N., Gajda M., et al. Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse. J Clin Oncol 2008, 26:1208-1215.
193. Páez D., Labonte M.J., Bohanes P., Zhang W., Benhanim L., Ning Y., et al. Cancer dormancy: a model of early dissemination and late cancer recurrence. Clin Cancer Res 2012, 18:645-653.
194. Pamme N. Magnetism and microfluidics. Lab Chip 2006, 6:24-38.
195. Pamme N. On-chip bioanalysis with magnetic particles. Curr Opin Chem Biol 2012, 16:436-443.
196. Pamme N., Manz A. On-chip free-flow magnetophoresis: continuous flow separation of magnetic particles and agglomerates. Anal Chem 2004, 76:7250-7256.
197. Pang R., Law W.L., Chu A.C.Y., Poon J.T., Lam C.S.C., Chow A.K.M., et al. A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer. Cell Stem Cell 2010, 6:603-615.
198. Pantel Klaus, Brakenhoff R.H. Dissecting the metastatic cascade. Nat Rev Cancer 2004, 4:448-456.
199. Pantel Klaus, Alix-Panabières C. The clinical significance of circulating tumor cells. Nat Clin Pract Oncol 2007, 4:62-63.
200. Pantel Klaus, Brakenhoff R.H., Brandt B. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer 2008, 8:329-340.
201. Pantel Klaus, Alix-Panabières C., Riethdorf S. Cancer micrometastases. Nat Rev Clin Oncol 2009, 6:339-351.
202. Paris P.L., Kobayashi Y., Zhao Q., Zeng W., Sridharan S., Fan T., et al. Functional phenotyping and genotyping of circulating tumor cells from patients with castration resistant prostate cancer. Cancer Lett 2009, 277:164-173.
203. Parkinson D.R., Dracopoli N., Petty B.G., Compton C., Cristofanilli M., Deisseroth A., et al. Considerations in the development of circulating tumor cell technology for clinical use. J Transl Med 2012, 10:138.
204. Paterlini-Brechot P., Benali N.L. Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett 2007, 253:180-204.
205. Pecot C.V., Bischoff F.Z., Mayer J.A., Wong K.L., Pham T., Bottsford-Miller J., et al. A novel platform for detection of CK+ and CK- CTCs. Cancer Discov 2011, 1:580-586.
206. Pethig Ronald Dielectrophoresis: using inhomogeneous AC electrical fields to separate and manipulate cells. Crit Rev Biotechnol 1996, 16:331-348.
207. Pierga J.-Y., Hajage D., Bachelot T., Delaloge S., Brain E., Campone M., et al. High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients. Ann Oncol 2012, 23:618-624.
208. Pitsillides C.M., Runnels J.M., Spencer J.A., Zhi L., Wu M.X., Lin C.P. Cell labeling approaches for fluorescence-based in vivo flow cytometry. Cytometry A 2011, 79:758-765.
209. Plouffe B.D., Mahalanabis M., Lewis L.H., Klapperich C.M., Murthy S.K. Clinically relevant microfluidic magnetophoretic isolation of rare-cell populations for diagnostic and therapeutic monitoring applications. Anal Chem 2012, 84:1336-1344.
210. Pouysségur J., Dayan F., Mazure N.M. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 2006, 441:437-443.
211. Powell A.A., Talasaz Amirali H., Zhang H., Coram M.A., Reddy A., Deng G., et al. Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines. PLoS One 2012, 7:e33788.
212. Pratt E.D., Huang C., Hawkins B.G., Gleghorn J.P., Kirby B.J. Rare cell capture in microfluidic devices. Chem Eng Sci 2011, 66:1508-1522.
213. Prince M.E., Sivanandan R., Kaczorowski A., Wolf G.T., Kaplan M.J., Dalerba P., et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A 2007, 104:973-978.
214. Punnoose E.A., Atwal S.K., Spoerke J.M., Savage H., Pandita A., Yeh R.-F., et al. Molecular biomarker analyses using circulating tumor cells. PLoS One 2010, 5:e12517.
215. Racila E., Euhus D., Weiss A.J., Rao C., McConnell J., Terstappen L.W., et al. Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci U S A 1998, 95:4589-4594.
216. Rao C.G., Chianese D., Doyle G.V., Miller M.C., Russell T., Sanders R.A., et al. Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors. Int J Oncol 2005, 27:49-57.
217. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111.
218. Rhim A.D., Mirek E.T., Aiello N.M., Maitra A., Bailey J.M., McAllister F., et al. EMT and dissemination precede pancreatic tumor formation. Cell 2012, 148:349-361.
219. Riethdorf S., Fritsche H., Müller V., Rau T., Schindlbeck C., Rack B., et al. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin Cancer Res 2007, 13:920-928.
220. Riethdorf S., Wikman H., Pantel Klaus Review: Biological relevance of disseminated tumor cells in cancer patients. Int J Cancer 2008, 123:1991-2006.
221. Ring A.E., Zabaglo L., Ormerod M.G., Smith I.E., Dowsett M. Detection of circulating epithelial cells in the blood of patients with breast cancer: comparison of three techniques. Br J Cancer 2005, 92:906-912.
222. Rosenberg R., Gertler R., Friederichs J., Fuehrer K., Dahm M., Phelps R., et al. Comparison of two density gradient centrifugation systems for the enrichment of disseminated tumor cells in blood. Cytometry 2002, 49:150-158.
223. Safarík I., Safaríková M. Use of magnetic techniques for the isolation of cells. J Chromatogr B Biomed Sci Appl 1999, 722:33-53.
224. Sahai E. Illuminating the metastatic process. Nat Rev Cancer 2007, 7:737-749.
225. Saliba A.-E., Saias L., Psychari E., Minc N., Simon D., Bidard François-Clément, et al. Microfluidic sorting and multimodal typing of cancer cells in self-assembled magnetic arrays. Proc Natl Acad Sci U S A 2010, 107:14524-14529.
226. Salnikov A.V., Liu L., Platen M., Gladkich J., Salnikova O., Ryschich E., et al. Hypoxia induces EMT in low and highly aggressive pancreatic tumor cells but only cells with cancer stem cell characteristics acquire pronounced migratory potential. PLoS One 2012, 7:e46391.
227. Santana S.M., Liu H., Bander N.H., Gleghorn J.P., Kirby B.J. Immunocapture of prostate cancer cells by use of anti-PSMA antibodies in microdevices. Biomed Microdevices 2012, 14:401-407.
228. Scheel C., Weinberg Robert A. Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Semin Cancer Biol 2012, 22:396-403.
229. Schenck J.F. Physical interactions of static magnetic fields with living tissues. Prog Biophys Mol Biol 2005, 87:185-204.
230. Schneider T., Moore L.R., Jing Y., Haam S., Williams P.S., Fleischman A.J., et al. Continuous flow magnetic cell fractionation based on antigen expression level. J Biochem Biophys Methods 2006, 68:1-21.
231. Scholtens T.M., Schreuder F., Ligthart S.T., Swennenhuis J.F., Greve J., Terstappen Leon W.M.M. Automated identification of circulating tumor cells by image cytometry. Cytometry A 2012, 81:138-148.
232. Shaw R.J., Cantley L.C. Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 2006, 441:424-430.
233. Shelby J.P., White J., Ganesan K., Rathod P.K., Chiu D.T. A microfluidic model for single-cell capillary obstruction by plasmodium falciparum-infected erythrocytes. Proc Natl Acad Sci U S A 2003, 100:14618-14622.
234. Sheng W., Chen T., Kamath R., Xiong X., Tan W., Fan Z.H. Aptamer-enabled efficient isolation of cancer cells from whole blood using a microfluidic device. Anal Chem 2012, 84:4199-4206.
235. Sidransky D. Nucleic acid-based methods for the detection of cancer. Science 1997, 278:1054-1059.
236. Sieben S., Bergemann C., Lübbe A., Brockmann B., Rescheleit D. Comparison of different particles and methods for magnetic isolation of circulating tumor cells. J Magn Magn Mater 2001, 225:175-179.
237. Sieuwerts A.M., Kraan J., Bolt J., van der Spoel P., Elstrodt F., Schutte M., et al. Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. J Natl Cancer Inst 2009, 101:61-66.
238. Singh A., Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 2010, 29:4741-4751.
239. Sleijfer S., Gratama J.-W., Sieuwerts A.M., Kraan J., Martens J.W.M., Foekens J.A. Circulating tumour cell detection on its way to routine diagnostic implementation?. Eur J Cancer 2007, 43:2645-2650.
240. Smith J.P., Barbati A.C., Santana S.M., Gleghorn J.P., Kirby B.J. Microfluidic transport in microdevices for rare cell capture. Electrophoresis 2012, 33:3133-3142.
241. Steeg P.S. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 2006, 12:895-904.
242. Stott S.L., Hsu C.-H., Tsukrov D.I., Yu M., Miyamoto D.T., Waltman B.A., et al. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc Natl Acad Sci U S A 2010, 107:18392-18397.
243. Sun Jiashu, Li M., Liu C., Zhang Yi, Liu D., Liu W., et al. Double spiral microchannel for label-free tumor cell separation and enrichment. Lab Chip 2012, 12:3952-3960.
244. Suresh S. Biomechanics and biophysics of cancer cells. Acta Biomater 2007, 3:413-438.
245. Szakács G., Paterson J.K., Ludwig J.A., Booth-Genthe C., Gottesman M.M. Targeting multidrug resistance in cancer. Nat Rev Drug Discov 2006, 5:219-234.
246. Talasaz AmirAli H., Powell A.A., Huber D.E., Berbee J.G., Roh K.-H., Yu W., et al. Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device. Proc Natl Acad Sci U S A 2009, 106:3970-3975.
247. Tan S.J., Yobas L., Lee G.Y.H., Ong C.N., Lim C.T. Microdevice for the isolation and enumeration of cancer cells from blood. Biomed Microdevices 2009, 11:883-892.
248. Tan S.J., Lakshmi R.L., Chen P., Lim W.-T., Yobas L., Lim C.T. Versatile label free biochip for the detection of circulating tumor cells from peripheral blood in cancer patients. Biosens Bioelectron 2010, 26:1701-1705.
249. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002, 2:442-454.
250. Tibbe Arjan G.J., Miller M.C., Terstappen Leon W.M.M. Statistical considerations for enumeration of circulating tumor cells. Cytometry A 2007, 71:154-162.
251. ® technology. Curr Chem Genomics 2012, 6:48-54.
252. Tuerk C., Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990, 249:505-510.
253. Uhr Jonathan W., Pantel Klaus Controversies in clinical cancer dormancy. Proc Natl Acad Sci U S A 2011, 108:12396-12400.
254. Van de Stolpe A., Pantel Klaus, Sleijfer S., Terstappen Leon W., den Toonder J.M.J. Circulating tumor cell isolation and diagnostics: toward routine clinical use. Cancer Res 2011, 71:5955-5960.
255. Van der Auwera I., Peeters D., Benoy I.H., Elst H.J., Van Laere S.J., Prové A., et al. Circulating tumour cell detection: a direct comparison between the cell search system, the AdnaTest and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancer. Br J Cancer 2010, 102:276-284.
256. Viator J.A., Gupta S., Goldschmidt B.S., Bhattacharyyal K., Kannan R., Shukla R., et al. Gold nanoparticle mediated detection of prostate cancer cells using photoacoustic flowmetry with optical reflectance. J Biomed Nanotechnol 2010, 6:187-191.
257. Visvader J.E., Lindeman G.J. Cancer stem cells: current status and evolving complexities. Cell Stem Cell 2012, 10:717-728.
258. Vona G., Sabile A., Louha M., Sitruk V., Romana S., Schütze K., et al. Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulatingtumor cells. Am J Pathol 2000, 156:57-63.
259. Vona Giovanna, Estepa L., Béroud C., Damotte D., Capron Frédérique, Nalpas B., et al. Impact of cytomorphological detection of circulating tumor cells in patients with liver cancer. Hepatology 2004, 39:792-797.
260. Wan Y., Kim Young-tae, Li N., Cho S.K., Bachoo R., Ellington A.D., et al. Surface-immobilized aptamers for cancer cell isolation and microscopic cytology. Cancer Res 2010, 70:9371-9380.
261. Wan Y., Tan J., Asghar W., Kim Young-tae, Liu Y., Iqbal S.M. Velocity effect on aptamer-based circulating tumor cell isolation in microfluidic devices. J Phys Chem B 2011, 115:13891-13896.
262. Wang S., Wang Hao, Jiao J., Chen K.-J., Owens G.E., Kamei K., et al. Three-dimensional nanostructured substrates toward efficient capture of circulating tumor cells. Angew Chem Int Ed Engl 2009, 48:8970-8973.
263. Wang S., Liu K., Liu Jian, Yu Z.T.-F., Xu Xiaowen, Zhao L., et al. Highly efficient capture of circulating tumor cells by using nanostructured silicon substrates with integrated chaotic micromixers. Angew Chem Int Ed Engl 2011, 50:3084-3088.
264. Wang Xu., Qian X., Beitler J.J., Chen Z.G., Khuri F.R., Lewis M.M., et al. Detection of circulating tumor cells in human peripheral blood using surface-enhanced Raman scattering nanoparticles. Cancer Res 2011, 71:1526-1532.
265. Weinberg Robert A. Mechanisms of malignant progression. Carcinogenesis 2008, 29:1092-1095.
266. Went P.T., Lugli A., Meier S., Bundi M., Mirlacher M., Sauter G., et al. Frequent EpCam protein expression in human carcinomas. Hum Pathol 2004, 35:122-128.
267. Wicha M.S., Liu S., Dontu G. Cancer stem cells: an old idea-a paradigm shift. Cancer Res 2006, 66:1883-1890. [discussion 1895-1896].
268. Willipinski-Stapelfeldt B., Riethdorf S., Assmann V., Woelfle U., Rau T., Sauter G., et al. Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells. Clin Cancer Res 2005, 11:8006-8014.
269. Wong E.C., Lee A., Shientag L., Yu J., Dong Y., Kao G., et al. Apoptosis: an early event in metastatic inefficiency. Cancer Res 2001, 61:333-338.
270. Woodhouse E.C., Chuaqui R.F., Liotta L.A. General mechanisms of metastasis. Cancer 1997, 80:1529-1537.
271. Yamada M., Seki M. Hydrodynamic filtration for on-chip particle concentration and classification utilizing microfluidics. Lab Chip 2005, 5:1233-1239.
272. Yamada M., Kano K., Tsuda Y., Kobayashi J., Yamato M., Seki M., et al. Microfluidic devices for size-dependent separation of liver cells. Biomed Microdevices 2007, 9:637-645.
273. Yang J., Huang Y., Wang X.B., Becker F.F., Gascoyne P.R. Cell separation on microfabricated electrodes using dielectrophoretic/gravitational field-flow fractionation. Anal Chem 1999, 71:911-918.
274. Yang L., Lang J.C., Balasubramanian P., Jatana K.R., Schuller D., Agrawal A., et al. Optimization of an enrichment process for circulating tumor cells from the blood of head and neck cancer patients through depletion of normal cells. Biotechnol Bioeng 2009, 102:521-534.
275. Yang Z.J., Chee C.E., Huang S., Sinicrope F.A. The role of autophagy in cancer: therapeutic implications. Mol Cancer Ther 2011, 10:1533-1541.
276. Yap B., Kamm R.D. Mechanical deformation of neutrophils into narrow channels induces pseudopod projection and changes in biomechanical properties. J Appl Physiol 2005, 98:1930-1939.
277. Yates D.R., Rouprêt M., Drouin S.J., Comperat E., Ricci S., Lacave R., et al. Quantitative RT-PCR analysis of PSA and prostate-specific membrane antigen mRNA to detect circulating tumor cells improves recurrence-free survival nomogram prediction after radical prostatectomy. Prostate 2012, 72:1382-1388.
278. Yu J.Q., Cristofanilli M. Circulating tumor cells and PET. J Nucl Med 2011, 52:1501-1504.
279. Yu M., Stott S., Toner Mehmet, Maheswaran S., Haber D.A. Circulating tumor cells: approaches to isolation and characterization. J Cell Biol 2011, 192:373-382.
280. Zabaglo Lila, Ormerod Michael G., Parton M., Ring A., Smith Ian E., Dowsett Mitch Cell filtration-laser scanning cytometry for the characterisation of circulating breast cancer cells. Cytometry A 2003, 55:102-108.
281. Zborowski M., Chalmers J. Commercial magnetic cell separation instruments and reagents. Laboratory techniques in biochemistry and molecular biology 2007, 265-292. Elsevier B.V., Amsterdam, Oxford.
282. Zborowski Maciej, Chalmers J.J. Rare cell separation and analysis by magnetic sorting. Anal Chem 2011, 83:8050-8056.
283. Zhang Yong, Kohler N., Zhang M. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials 2002, 23:1553-1561.
284. Zhang Liling, Riethdorf S., Wu G., Wang T., Yang K., Peng G., et al. Meta-analysis of the prognostic value of circulating tumor cells in breast cancer. Clin Cancer Res 2012, 18:5701-5710.
285. Zhao Y., Schiro P.G., Kuo J.S., Ng Laiying, Chiu D.T. Method for the accurate preparation of cell-spiking standards. Anal Chem 2009, 81:1285-1290.
286. Zheng S., Lin H., Liu J.-Q., Balic M., Datar R., Cote R.J., et al. Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells. J Chromatogr A 2007, 1162:154-161.
287. Zheng X., Cheung L.S.-L., Schroeder Joyce A., Jiang L., Zohar Yitshak A high-performance microsystem for isolating circulating tumor cells. Lab Chip 2011, 11:3269-3276.
288. Zheng X., Cheung L.S.-L., Schroeder Joyce A., Jiang L., Zohar Yitshak Cell receptor and surface ligand density effects on dynamic states of adhering circulating tumor cells. Lab Chip 2011, 11:3431-3439.
289. Zhu Z., Hao X., Yan M., Yao M., Ge C., Gu J., et al. Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma. Int J Cancer 2010, 126:2067-2078.
290. Zieglschmid V., Hollmann C., Gutierrez B., Albert W., Strothoff D., Gross E., et al. Combination of immunomagnetic enrichment with multiplex RT-PCR analysis for the detection of disseminated tumor cells. Anticancer Res 2005, 25:1803-1810.
291. Zigeuner R.E., Riesenberg R., Pohla H., Hofstetter A., Oberneder R. Isolation of circulating cancer cells from whole blood by immunomagnetic cell enrichment and unenriched immunocytochemistry in vitro. J Urol 2003, 169:701-705.
292. Zippelius A., Lutterbüse R., Riethmüller G., Pantel K. Analytical variables of reverse transcription-polymerase chain reaction-based detection of disseminated prostate cancer cells. Clin Cancer Res 2000, 6:2741-2750.